Xian Zhou, Xianjin Zhou, Huimin Shi, Jie Lai, Qingping Wang, Yi Li, Kun Chen, Qingjian Li, Qiang Zhou, Xia Cao, Bobin Chen, Jianjiang Xiao
BACKGROUND: Intravitreal methotrexate has been proven to be an effective treatment method for vitreoretinal lymphoma. However, keratopathy occurs as the major side effect during treatment in most cases. The purpose of this study is to describe the characteristics of primary central nervous system lymphoma (PCNSL) with intraocular involvement and to attempt to reduce the incidence of keratopathy caused by intravitreal methotrexate. METHODS: The medical records of 22 PCNSL patients with intraocular involvement (33 eyes) were reviewed...
May 12, 2020: BMC Ophthalmology